Fundraising FoxUpstream Biotechnology
Durham, US · 5 known investors
Find your way into Upstream Biotechnology
Sign up to see every warm intro you have to Upstream Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Upstream Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Upstream Biotechnology develops seed-based crop technologies that enhance plant immunity and resilience using RNA-based SwitchBlade platform. The company translates foundational plant-immunity science into commercial agricultural solutions for seed-company partnerships.
Founders & leadership
GH
George H. GreeneCEO & Co-Founder
XW
Xiao-fang WangNamed on SEC filing
XD
Xinnian DongCo-Founder
Board
Investors · 5
Reported raises · per SEC filings
Form D private placements$625K disclosed across 1 round · 2025
▶$625KraisedSep 2025 · 3 investors · Other TechnologyRule 506(b)
▶$625KraisedSep 2025 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Karen LeVertDirector
- Xiao-fang WangDirector
- George H. GreeneExecutive Officer, Director
- Xinnian DongDirector
- Offering amount
- $1.6M
- Amount sold
- $625K
- First sale
- Aug 2025
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Upstream BioUpstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation. It works with clinical study staff, principal investigators, and healthcare practitioners at study sites conducting its trials.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies working in the same space as Upstream Biotechnology.
Frequently asked questions
- What does Upstream Biotechnology do?
- Upstream Biotechnology develops seed-based crop technologies that enhance plant immunity and resilience using RNA-based SwitchBlade platform. The company translates foundational plant-immunity science into commercial agricultural solutions for seed-company partnerships.
- Who are Upstream Biotechnology's investors?
- Upstream Biotechnology's investors include Ag Ventures Alliance, AgLaunch Accelerator, LeVert Ventures, Middleland Capital, Redstick Ventures.
- How much funding has Upstream Biotechnology raised?
- Upstream Biotechnology has disclosed $625K raised across 1 round.
- Where is Upstream Biotechnology headquartered?
- Upstream Biotechnology is headquartered in Durham, US.